Section 1 Diagnoses of HIV Infection and Diagnoses of Infection Classified as Stage 3 (AIDS) 1a Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2010-2015-United States 1b Diagnoses of HIV infection, by year of diagnosis and selected characteristics, 2010-2015-United States and 6 dependent areas 2a Stage 3 (AIDS), by year of diagnosis and selected characteristics, 2010-2015 and cumulative-United States 2b Stage 3 (AIDS), by year of diagnosis and selected characteristics, 2010-2015 and cumulative-United States and 6 dependent areas 3a Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2015-United States 3b Diagnoses of HIV infection, by race/ethnicity and selected characteristics, 2015-United States and 6 dependent areas 4a Stage 3 (AIDS), by race/ethnicity and selected characteristics, 2015-United States 4b Stage 3 (AIDS), by race/ethnicity and selected characteristics, 2015-United States and 6 dependent areas 5a Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2015-United States 5b Diagnoses of HIV infection, by transmission category, race/ethnicity, and selected characteristics, 2015-United States and 6 dependent areas 6a Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2015-United States 6b Stage 3 (AIDS), by transmission category, race/ethnicity, and selected characteristics, 2015-United States and 6 dependent areas 7a Diagnoses of HIV infection among children aged <13 years, by race/ethnicity, 2010-2015-United States 7b Diagnoses of HIV infection among children aged <13 years, by race/ethnicity, 2010-2015-United States and 6 dependent areas 8a Stage 3 (AIDS) among children aged <13 years, by race/ethnicity, 2010-2015 and cumulative-United States 8b Stage 3 (AIDS) among children aged <13 years, by race/ethnicity, 2010-2015 and cumulative-United States and 6 dependent areas 9 Stage 3 (AIDS) among children aged <13 years, by year of diagnosis, 1992-2015-United States and 6 dependent areas 10 Diagnoses of HIV infection among adult and adolescent Hispanics/Latinos, by transmission category and place of birth, 2015-United States and 6 dependent areas 11 Stage 3 (AIDS) among adult and adolescent Hispanics/Latinos, by transmission category and place of birth, 2015-United States and 6 dependent areas Section 2 Deaths and Survival after a Diagnosis of HIV Infection or Stage 3 (AIDS) Classification 12a Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2010-2014-United States 12b Deaths of persons with diagnosed HIV infection, by year of death and selected characteristics, 2010-2014-United States and 6 dependent areas 13a Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by year of death and selected characteristics, 2010-2014 and cumulative-United States 13b Deaths of persons with diagnosed HIV infection ever classified as stage 3 (AIDS), by year of death and selected characteristics, 2010-2014 and cu...
Introduction As people with HIV (PWH) age, they experience prolonged exposure to HIV and antiretroviral therapy, increased risks of developing age‐related HIV‐associated non‐AIDS (HANA) comorbidities and higher rates of hospitalization. Few studies have explored the ageing of PWH and its impact on hospital stays in the US. This study examined trends, characteristics and comorbidities associated with hospital stays with HIV (HSWH) as compared with hospital stays without HIV (HSWOH). Methods Thirteen years of pooled National Inpatient Sample (NIS) data from 2003 through 2015 were analysed to describe yearly trends. Trends were evaluated for eight major HANA conditions (cardiovascular disease, cancer, diabetes, liver disease, bone loss, kidney disease, pulmonary disease and neurological disease) across four age groups (18–34, 35–49, 50–64, 65+ years). Results Although overall rates of hospitalization reduced across all age groups, the proportion of HIV‐related hospitalization increased among older Americans. The average number of chronic conditions was higher for HSWH among all age groups and disproportionately increased for older PWH. Although age‐adjusted rates of cardiovascular disease, cancer, bone loss and pulmonary disease were lower for HSWH relative to HSWOH, rates increased disproportionately over the study period. The prevalence of all major HANA conditions except cancer and diabetes increased among the elderly (65+), and the prevalence of cardiovascular disease, cancer, bone loss, kidney disease and pulmonary disease also increased among patients aged 50–64 years. Conclusions Higher rates of hospitalizations and HANA comorbidities were observed among older HIV patients. The ageing of PWH suggests increased future hospital resource utilization for HSWH. Appropriate training of healthcare providers is essential to managing increased comorbidity burdens of older PWH during hospital stays in the US.
Human immunodeficiency virus (HIV) testing is important for controlling the epidemic in low- and middle-income countries such as the Dominican Republic (DR) – a country in the Caribbean. This study aimed to examine factors associated with HIV testing in the DR. The study used HIV test data in the 2013 DR Demographic and Health Survey. HIV data were collected from 18,614 individuals aged 15–59 years. Wealth status, HIV-related stigma, and knowledge scales were constructed using factor analysis. Survey-weighted logistic regression was used to identify correlates of HIV testing in the DR. Results show that almost two-thirds (62.4%) of the participants reported ever having an HIV test. In the multivariable analysis, older age, higher education, female gender, richest wealth status, health insurance, married, higher HIV-knowledge, and lower HIV-related stigma increased the likelihood of getting an HIV test in the DR. People living in Norte/Cibao, which had a higher HIV prevalence, had a lower chance of having an HIV test than people living in the Este/Sureste region. Although HIV testing has increased in recent times, it is not yet satisfactory in the DR. Specific interventions building HIV awareness targeting specific sub-populations and regions will increase knowledge on HIV and reduce HIV-related stigma, and may increase HIV testing.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.